IVIVC and Biowaivers in Drug Development 2012 seminar to take place in India

In-Vitro In-Vivo Correlation and Biowaivers in Drug Development

30-31 October, Mumbai, India

UBM Conferences brings to you the two-day conceptual seminar, IVIVC and Biowaivers 2012, taking place from October 30-31 in Mumbai, India.

This focussed seminar is aimed at providing training for pharmaceutical professionals from R&D, Formulation development, Formulation Analytical, Bioequivalence, Clinical, Regulatory, Strategic QA and Biostatisticians on the scope, limitations, potential pitfalls, inherent inadequacies, mechanics, utility and application of In-Vitro In-Vivo Correlation (IVIVC) in drug development ultimately leading to biowaivers.

Key researchers, industry and academic experts who have confirmed their attendance include: Dr. Vinod P Shah, a Distinguished Pharmaceutical Scientist and a consultant at USP, Dr. Umesh Banakar, Professor & President, Banakar Consulting Services, Independent Consultant/Advisor to Pharmaceutical Industry and Academia worldwide USA, Dr. Bhupinder Singh Bhoop, Professor (Pharmaceutics & Biopharmaceutics), University Institute of Pharmaceutical Sciences, Panjab University, India, globally acclaimed for his scientific work on "Formulation by Design (FbD)" and IVIVC Dr. V Venkateswarlu, Vice President, Dr. Reddy's Laboratories, India, Dr. Jyoti K Paliwal, Professor in Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), India, Dr. Deepika Aggarwal, Senior Manager, Dr. Reddy's Laboratories, India.

This event provides expert talks, presentation and discussions on examining the application of IVIVC in reducing the number of human studies in formulation development and understanding its role as an In vivo bioavailability substitute to support biowaivers.

Visit www.ivivc-biowaivers.com/pr to view the complete programme.